231 filings
Page 8 of 12
8-K
h7f5dqnb
7 Nov 18
Axovant Announces Second Fiscal Quarter 2018 Financial Results and Corporate Updates
12:00am
8-K
q7fr7885m4h zu1seh
2 Oct 18
Departure of Directors or Certain Officers
4:16pm
CT ORDER
b9v3qoc01s lt
28 Aug 18
Confidential treatment order
12:00am
8-K
1aocq90915a
17 Aug 18
Submission of Matters to a Vote of Security Holders
4:27pm
S-8
cu108
16 Aug 18
Registration of securities for employees
5:23pm
8-K
ibw7s xxj
7 Aug 18
Axovant Announces First Fiscal Quarter 2018 Financial Results and Corporate Update
12:00am
8-K
6s5eqdjn5b
9 Jul 18
Entry into a Material Definitive Agreement
6:13am
8-K
coz60z5hnluszi
22 Jun 18
Entry into a Material Definitive Agreement
5:28pm
424B5
n6qehkhc
22 Jun 18
Prospectus supplement for primary offering
5:28pm
DEF 14C
1rk71u sq
18 Jun 18
Information statement
7:00am
PRE 14C
arr7jcoxq00
7 Jun 18
Preliminary information
6:03am
8-K
977fy2wkf sxccym2tbw
6 Jun 18
Axovant Licenses Investigational Gene Therapy for Parkinson’s Disease from Oxford BioMedica and Announces Key Leadership Team Addition
6:02am
8-K/A
sbsl0a v2aw
14 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K/A
wcpxei d6
7 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
gb1a8n6hn cw
14 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K/A
d4w2fgebl9k0i 0c7
9 Jan 18
Other Events
12:00am